Atezolizumab Plus Bevacizumab With HCC and HBV Infection

NCT04180072 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]